Comparison of Drainage Methods in Minimally Invasive Esophagectomy (DEMURE)
Comparison of the Application Effects of Different Drainage Modes in the Perioperative Period of Minimally Invasive Three-Field Radical Esophagectomy for Esophageal Cancer
1 other identifier
interventional
75
1 country
1
Brief Summary
This RCT compares three drainage approaches after minimally invasive esophagectomy (chest tube + thoracic mediastinal drainage tube, thoracic, and abdominal mediastinal drainage tube) to evaluate perioperative outcomes, addressing current evidence gaps in pain and complication profiles.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 30, 2025
CompletedFirst Submitted
Initial submission to the registry
May 5, 2025
CompletedFirst Posted
Study publicly available on registry
June 4, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2026
CompletedJune 10, 2025
April 1, 2025
1 year
May 5, 2025
June 5, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postoperative Pain Scores
Pain scores were assessed based on the visual analog scale according to the World Health Organization guidelines, in which 0 indicated no pain and 10 indicated the worst possible pain. We also recorded and evaluated maximum daily pain scores when pain caused by the mediastinal drainage tube incision.
Pain scores were recorded at different times during the postoperative period when the patients were quiet and active (at 7 AM, 11 AM, 3 PM, and 7 PM) from postoperative day 1 to postoperative day 4.
Secondary Outcomes (1)
Postoperative complications
Postoperative complications from posoperative day 1 to postoperative month 3
Study Arms (3)
Abdominal mediastinal tube
EXPERIMENTALTransperitoneal mediastinal drainage was performed for postoperative management of the patient.
Chest mediastinal tube
EXPERIMENTALTransthoracic mediastinal drainage was performed for postoperative management of the patient.
Chest tube + chest mediastinal tube
EXPERIMENTALChest tube insertion combined with transthoracic mediastinal drainage was performed for postoperative management of the patient.
Interventions
Transthoracic mediastinal drainage was performed for postoperative management of the patient.
Transperitoneal mediastinal drainage was performed for postoperative management of the patient.
Chest tube insertion combined with transthoracic mediastinal drainage was performed for postoperative management of the patient.
Eligibility Criteria
You may qualify if:
- Age ≥18 years
- Pathologically confirmed esophageal cancer requiring three-incision esophagectomy (cervical, thoracic, and abdominal incisions)
- ASA physical status class I-III
You may not qualify if:
- History of chronic pain or long-term use of analgesics prior to surgery
- Severe cardiopulmonary dysfunction (e.g., FEV1 \<50%)
- Coagulation disorders or patients undergoing reoperation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ruijin Hospitallead
Study Sites (1)
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, 200025, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hecheng Li, PhD, MD
Ruijin Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 5, 2025
First Posted
June 4, 2025
Study Start
April 30, 2025
Primary Completion
May 1, 2026
Study Completion
August 1, 2026
Last Updated
June 10, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will share
De-identified baseline characteristics, outcomes, and adverse events.